The company's P/S ratio is high in contrast to its lower pro...
The company's P/S ratio is high in contrast to its lower projected growth, a divergence that could bring risk to shareholders and potential investors. The current P/S ratio might not sustain due to predicted future revenues.
Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) Shares Climb 36% But Its Business Is Yet to Catch Up
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment